CD4 Gene - CD4 Molecule | T-Cell Co-Receptor and HIV Receptor

Complete genetic, functional, and clinical reference for the CD4 gene, including expression data, mutations, and disease associations.

Gene Information Card

Symbol CD4
Full Name CD4 molecule
Gene Type protein coding
Chromosomal Location 12p13.31
NCBI Gene ID 920 ncbi.nlm.nih.gov/gene/920
Ensembl ID ENSG00000010610
UniProt ID P01730
OMIM ID 186940
HGNC ID 1678
Aliases CD4 antigen, T-cell surface glycoprotein CD4, T-cell differentiation antigen L3T4, OKT4

Description

The CD4 gene encodes the CD4 protein, a single-pass type I membrane glycoprotein that serves as a co-receptor for the T-cell receptor (TCR) on helper T cells. It is essential for the recognition of antigens presented by MHC class II molecules on antigen-presenting cells. CD4 also functions as the primary high-affinity receptor for the human immunodeficiency virus (HIV), facilitating viral entry into host cells. The protein is composed of four immunoglobulin-like domains (D1-D4), with the D1 domain binding to the beta-2 domain of MHC class II and the gp120 envelope protein of HIV. CD4 is expressed on the surface of helper T cells, regulatory T cells, monocytes, macrophages, and dendritic cells. Its expression is critical for the development and function of the adaptive immune system.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
HIV/AIDS CD4 serves as the primary receptor for HIV-1 and HIV-2. The viral gp120 envelope protein binds to the D1 domain of CD4, triggering a conformational change that allows co-receptor (CCR5 or CXCR4) binding and subsequent viral entry. Progressive depletion of CD4+ T cells leads to immunodeficiency. OMIM 186940; NCBI Gene
Idiopathic CD4 Lymphopenia A rare syndrome characterized by persistently low CD4+ T-cell counts (<300 cells/µL) without evidence of HIV infection. Genetic variants in CD4 or other immune-related genes may contribute to impaired T-cell development or survival, though the exact mechanism is often unclear. OMIM 186940; ClinVar
Immunodeficiency 65 A rare primary immunodeficiency caused by homozygous mutations in the CD4 gene, leading to a complete absence of CD4 expression on T cells. This results in impaired T-cell help, reduced antibody responses, and increased susceptibility to infections. OMIM 186940; ClinVar
Cutaneous T-Cell Lymphoma CD4 is expressed on malignant T cells in mycosis fungoides and Sézary syndrome. The CD4 expression is used as a diagnostic marker and therapeutic target, though the gene itself is not typically mutated. COSMIC; NCBI Gene

Expression Profile

Tissue Expression
Tissue nTPM level
Spleen 17.2 High
Lymph Node 15.8 High
Blood 14.5 High
Bone Marrow 8.3 Medium
Lung 4.1 Low
Small Intestine 3.2 Low
Cell Line Expression
Cell Line nTPM Notes
Jurkat (T-cell leukemia) 25.4 High expression; commonly used model for T-cell signaling
MOLT-4 (T-cell leukemia) 22.1 High expression
THP-1 (Monocytic leukemia) 12.3 Medium expression; monocyte lineage
U937 (Histiocytic lymphoma) 9.8 Medium expression; monocyte lineage
K-562 (CML) 0.2 No significant expression
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.448C>T (p.Arg150Cys) Missense Rare Disrupts D1 domain structure, impairing MHC class II binding and HIV gp120 interaction
c.1216C>T (p.Arg406Ter) Nonsense Rare Premature truncation, leading to loss of cytoplasmic tail and impaired signaling
c.1A>G (p.Met1Val) Start codon loss Rare Complete loss of protein expression; associated with Immunodeficiency 65
c.1024_1025del (p.Leu342fs) Frameshift Rare Frameshift leading to truncated protein and loss of function
Mutation functional classification

Loss of Function (LOF)

Most CD4 mutations are loss-of-function, resulting in reduced or absent CD4 protein expression on the cell surface. This leads to impaired T-cell help, defective immune responses, and increased susceptibility to infections. Homozygous loss-of-function mutations cause Immunodeficiency 65.

Gain of Function (GOF)

No gain-of-function mutations have been reported for CD4. The protein's function is tightly regulated, and increased activity would likely lead to autoimmunity, but such variants have not been documented.

Dominant Negative (DN)

No dominant-negative mutations have been described for CD4. Since CD4 functions as a monomer on the cell surface, a single mutant allele is unlikely to exert a dominant-negative effect. Heterozygous carriers of loss-of-function mutations are typically asymptomatic.

Gene Ontology (GO)

• protein binding • MHC class II protein binding
• coreceptor activity • identical protein binding
• plasma membrane • integral component of membrane
• T cell receptor signaling pathway • cell surface receptor signaling pathway
• immune response • viral entry into host cell

Pathways

T cell receptor signaling pathway
HIV lifecycle
Adaptive Immune System
PD-1 signaling
Costimulation by the CD28 family

Protein Summary

The CD4 protein is a 458-amino-acid type I transmembrane glycoprotein with a molecular weight of approximately 55 kDa. It consists of four extracellular immunoglobulin-like domains (D1-D4), a single transmembrane region, and a short cytoplasmic tail. The D1 domain is critical for binding to MHC class II molecules and HIV gp120. The cytoplasmic tail interacts with the tyrosine kinase Lck, which is essential for TCR signaling. CD4 is expressed on helper T cells, regulatory T cells, monocytes, macrophages, and dendritic cells. It plays a central role in the adaptive immune response by stabilizing the TCR-MHC class II interaction and enhancing T-cell activation. As the primary receptor for HIV, CD4 is a major target for therapeutic interventions, including monoclonal antibodies (e.g., ibalizumab) and entry inhibitors.

Related Products

Product name Cat.No. Species Gene ID
CD40 Knockout HEK293 Cell Line EDJ-KQ553 Human 958 Details Get a Quote
CD40LG Knockout HEK293 Cell Line EDJ-KQ554 Human 959 Details Get a Quote
PLCD4 Knockout HEK293 Cell Line EDJ-KQ1617 Human 84812 Details Get a Quote
CD47 Knockout HEK293 Cell Line EDJ-KQ1969 Human 961 Details Get a Quote
CD44 Knockout HEK293 Cell Line EDJ-KQ3375 Human 960 Details Get a Quote
PDCD4 Knockout HEK293 Cell Line EDJ-KQ3907 Human 27250 Details Get a Quote
ABCD4 Knockout HEK293 Cell Line EDJ-KQ5612 Human 5826 Details Get a Quote
C2CD4C Knockout HEK293 Cell Line EDJ-KQ8148 Human 126567 Details Get a Quote
C2CD4A Knockout HEK293 Cell Line EDJ-KQ10451 Human 145741 Details Get a Quote
HACD4 Knockout HEK293 Cell Line EDJ-KQ11639 Human 401494 Details Get a Quote
C2CD4B Knockout HEK293 Cell Line EDJ-KQ12602 Human 388125 Details Get a Quote
C2CD4D Knockout HEK293 Cell Line EDJ-KQ12603 Human 100191040 Details Get a Quote
CD4 Knockout HEK293 Cell Line EDJ-KQ17684 Human 920 Details Get a Quote
CD48 Knockout HEK293 Cell Line EDJ-KQ17741 Human 962 Details Get a Quote
CD46 Knockout HEK293 Cell Line EDC09605 Human 4179 Details Get a Quote
Displaying Records 1 To 15 Of 72 Records
Contact Us
*
*
*
*
How did you hear about us: